Walgreens Boots Alliance : Statement of Changes in Beneficial Ownership (Form 4) (2024)

Market Closed - Nasdaq Other stock markets 04:00:00 2024-08-13 pm EDT			5-day change	1st Jan Change
10.56 ^USD	+3.53%		-3.21%	-59.56%

Aug. 09	Walgreens Boots Alliance Prices $750 Million Notes Offering	MT
Aug. 08	Global markets live: Amazon, Intel, Boeing, Robinhood, KKR, Zillow...

Summary

Quotes

Charts

News

Company

Financials

Valuation

Consensus

Ratings

Calendar

Sector

ETFs

April 29, 2022 at 10:14 pm EDT

Ownership Submission

FORM 4

Check this box if no longer subject to Section 16, Form 4 or Form 5 obligations may continue. See Instruction 1(b).

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934 or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:3235-0287Expires:January 31, 2005Estimated average burden hours per response...0.5

1. Name and Address of Reporting Person ^*

Kehoe James

2. Issuer Name and Ticker or Trading Symbol
Walgreens Boots Alliance, Inc. [WBA]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

_____ Director	_____ 10% Owner
_____ Officer (give title below)	_____ Other (specify below)
EVP and Global CFO /

(Last)	(First)	(Middle)
C/O WALGREENS BOOTS ALLIANCE, INC. , 108 WILMOT ROAD

3. Date of Earliest Transaction (Month/Day/Year)

(Street)
DEERFIELD	IL	60015

4. If Amendment, Date Original Filed(Month/Day/Year)

6. Individual or Join/Group Filing(Check Applicable Line)
_X_ Form filed by One Reporting Person
___ Form filed by More than One Reporting Person

(City)

(State)

(Zip)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned

1.Title of Security	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code	4. Securities Acquired (A) or Disposed of (D)	5. Amount of Securities Beneficially Owned Following Reported Transaction(s)	6. Ownership Form: Direct (D) or Indirect (I)	7. Nature of Indirect Beneficial Ownership
Code	V	Amount	(A) or (D)	Price

Table II - Derivative Securities Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
(e.g., puts, calls, warrants, options, convertible securities)

1. Title of Derivate Security	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code	5. Number of Derivative Securities Acquired (A) or Disposed of (D)	6. Date Exercisable and Expiration Date	7. Title and Amount of Securities Underlying Derivative Security	8. Price of Derivative Security	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s)	10. Ownership Form of Derivative Security: Direct (D) or Indirect (I)	11. Nature of Indirect Beneficial Ownership
Code	V	(A)	(D)	Date Exercisable	Expriation Date	Title	Amount or Number of Shares

Reporting Owners

Reporting Owner Name / Address	Relationships
Director	10% Owner	Officer	Other
Kehoe James C/O WALGREENS BOOTS ALLIANCE, INC. 108 WILMOT ROAD DEERFIELD, IL60015			EVP and Global CFO

Signatures

/s/ James Kehoe by Paul Ingram, Attorney-in-Fact	2022-04-29
^**Signature of Reporting Person	Date

Explanation of Responses:

*()**	If the form is filed by more than one reporting person, see Instruction 5(b)(v).
()**	Intentional misstatements or omissions of facts constitute Federal Criminal Violations. See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
(1)	On April 27, 2022, the Compensation and Leadership Performance Committee determined that the performance criteria applicable to this restricted stock unit award granted on May 1, 2021 (not a derivative security within the meaning of Rule 16a-1(c) upon grant) under the Walgreens Boots Alliance, Inc. 2021 Omnibus Incentive Plan, as amended (together with the related award agreement and the applicable election forms thereunder, the "Plan") had been satisfied. The shares underlying these restricted stock units will vest on the first anniversary of the grant date, subject to the terms and conditions of the Plan.
(2)	Includes shares underlying restricted stock units issued in lieu of dividends (through April 15, 2022) on outstanding restricted stock units, including 733 shares with respect to the restricted stock unit award described in note (1) above.

Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, See Instruction 6 for procedure.Potential persons who are to respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB number.

Attachments

Original Link
Original Document
Permalink

Disclaimer

Walgreens Boots Alliance Inc. published this content on 29 April 2022 and is solely responsible for the information contained therein. Distributed by Public, unedited and unaltered, on 30 April 2022 02:13:06 UTC.

Latest news about Walgreens Boots Alliance, Inc.

Walgreens Boots Alliance Prices $750 Million Notes Offering	Aug. 09	MT
Global markets live: Amazon, Intel, Boeing, Robinhood, KKR, Zillow...	Aug. 08
Nasdaq's wild mood swings	Aug. 08
Walgreens explores options for selling VillageMD business	Aug. 07	RE
Walgreens Mulls Sale of VillageMD	Aug. 07	DJ
Walgreens, Instacart Partner to Accept Online Snap/EBT Payments	Aug. 06	MT
Walgreens Plans to Sell Another Slice of Its Cencora Stake for $1.1 Billion	Aug. 02	CI
Global markets live: Wells Fargo, Nintendo, Apple, Amazon, Alphabet...	Aug. 02
Sector Update: Health Care Stocks Decline Premarket Friday	Aug. 02	MT
Walgreens Boots Alliance Sells Cencora Shares for $1.1 Billion	Aug. 02	MT
Walgreens further reduces stake in Cencora	Aug. 01	RE
Walgreens sells shares in Cencora for about $1.1 billion	Aug. 01	RE
HSBC Adjusts Price Target on Walgreens Boots Alliance to $7 From $11	Jul. 25	MT
GDP High, Nasdaq Sigh	Jul. 25
ANALYST RECOMMENDATIONS : Sirius Xm, Tesla, Chipotle, Spotify, Walgreens Boots...	Jul. 25
Barclays Adjusts Price Target on Walgreens Boots Alliance to $7 From $11	Jul. 22	MT
	Jul. 19	DJ
Walgreens Boots Alliance, Inc.(NasdaqGS:WBA) dropped from NASDAQ-100 Index	Jul. 18	CI
	Jul. 15	CI
Walgreens Boots Alliance, Inc. Appoints William H. Shrank to Board of Directors	Jul. 10	CI
Walgreens Boots Alliance Keeps Quarterly Dividend at $0.25 a Share, Payable Sept. 12 to Shareholders of Record Aug. 21	Jul. 10	MT
Walgreens Boots Alliance, Inc. Declares Quarterly Dividend, Payable on September 12, 2024	Jul. 10	CI
Baptista Research Upgrades Walgreens Boots Alliance to Outperform From Hold, Price Target is $13.70	Jul. 09	MT
Top Decliners	Jul. 03	MT
UBS Adjusts Price Target on Walgreens Boots Alliance to $12 From $17, Maintains Neutral Rating	Jul. 03	MT

Chart Walgreens Boots Alliance, Inc.

Duration

Period

More charts

Company Profile

Walgreens Boots Alliance, Inc. specializes in the distribution of pharmaceutical products. Net sales break down by activity as follows:- retail distribution (87.2%): selling prescription drugs, OTC medicines, beauty and cosmetic products, etc. in the United States (90.9% of net sales) and internationally (9.1%). At the end of August 2023, the activity is carried out through 13,532 outlets (of which 8,706 located in the United States, Puerto Rico and the US Virgin Islands), and through the Internet;- wholesale distribution (8.1%).The remaining sales (4.7%) are from the healthcareNet sales break down geographically as follows: the United States (84%), Germany (8.1%), the United Kingdom (6.5%) and other (1.4%).

Employees

268,500

Sector

Drug Retailers

Calendar

2024-08-20 - Détachement de

Related indices

More about the company

Income Statement and Estimates

More financial data

Analysis / Opinion

Walgreens CEO on Narrowed Forecast, Shoppers Cutting Back Spending March 28, 2024 at 03:59 pm EDT

Walgreens Boots Alliance, Inc. first light at the end of the tunnel? November 27, 2023 at 10:22 am EST

More Strategies

Ratings

Trading Rating

Investor Rating

ESG Refinitiv

B-

More Ratings

Analysts' Consensus

Sell

Buy

Mean consensus

HOLD

Number of Analysts

Last Close Price

10.20USD

Average target price

13.62USD

Spread / Average Target

+33.52%

Consensus

Profit revisions

Estimate revisions

Quarterly earnings, Rate of surprise

Company calendar

Stock Market
Equities
WBA Stock
News Walgreens Boots Alliance, Inc.
Walgreens Boots Alliance : Statement of Changes in Beneficial Ownership (Form 4)

Secure and Increase the Performance of your Investments with our Team of Experts at your Side Secure my Investments

"); for (var element in ICConf) { if (document.getElementById("zpp"+element)) { document.getElementById("zpp"+element).innerHTML = ""; } } InvestingChannelQueue.push(function() { ic_page = InvestingChannel.UAT.Run("5c5a75c3-8896-4592-98f8-dc06e6fdcc56"); }); } gaEvent('adspv', 'InvestingChannel_v2', 'US');googletag.cmd.push(function() { googletag.pubads().setTargeting('Edition', 'en_US');googletag.pubads().setTargeting('UserType', 'free');googletag.pubads().setTargeting('Content', 'equities');googletag.pubads().setTargeting('codezb', '19356230');googletag.enableServices();googletag.pubads().collapseEmptyDivs();try{googletag.pubads().getSlots().forEach(function(slot){if(slot.getSlotElementId().startsWith('zpp')){;}else{googletag.pubads().refresh([slot],{changeCorrelator: false});}})}catch(error){console.error(error)}});$(document).ready(function() { $( document).on('zbv_visible',function () {startAdsService();}); if (document[zbv_hidden]===false) { startAdsService(); } });

Walgreens Boots Alliance : Statement of Changes in Beneficial Ownership (Form 4) (2024)

Latest news about Walgreens Boots Alliance, Inc.

Chart Walgreens Boots Alliance, Inc.

Company Profile

Income Statement and Estimates

Analysis / Opinion

Ratings

Analysts' Consensus

Quarterly earnings, Rate of surprise

References